SCANSOURCE CEO Exercises Options and Disposes 150,000 Shares

Rhea-AI Filing Summary

SCANSOURCE, INC. insider Michael L. Baur executed option exercises and share sales on September 17-18, 2025. The filing shows exercises of employee stock options at an exercise price of $38.19 for a total of 125,000 underlying shares (102,031 on 09/17 and 22,969 on 09/18), resulting in reported beneficial ownership of 250,481 shares after the 09/18 transactions. Concurrently, the reporting person sold 150,000 shares across two days at weighted-average prices of $44.96 and $44.34, reducing direct holdings to 202,512 shares after 09/18. The option grant vested in three annual installments beginning 12/04/2016.

Positive

• Option exercises converted previously granted employee stock options into shares at a $38.19 exercise price, realizing gains when sold at higher weighted-average prices
• Reporting transparency: footnotes disclose weighted-average sale price ranges and offer further breakdowns on request

Negative

• Insider sales totaled 150,000 shares on 09/17-09/18/2025, which reduced direct beneficial ownership from 329,543 to 202,512 shares
• Concentrated insider role: the reporting person is CEO, President and Board Chair; sizeable sales by a principal executive may attract investor scrutiny

Insights

Financial Analyst

TL;DR: Insider exercised options and sold shares, realizing gains while retaining substantial ownership.

The filing documents two option exercises totaling 125,000 underlying shares at a $38.19 exercise price and subsequent sales of 150,000 shares at weighted-average prices of $44.96 and $44.34. The exercises required cash or share-settlement to obtain 125,000 shares, which were largely sold. Post-transactions direct beneficial ownership is reported as 202,512 shares. These transactions realize the spread between exercise price and sale price, and the remaining holdings indicate continued ownership alignment with shareholders. No additional material financial metrics or company guidance are disclosed.

Corporate Governance Expert

TL;DR: Transactions are routine for vested option holders but warrant monitoring for timing and frequency.

The report identifies the reporting person as CEO, President and Board Chair and shows option vesting originally set in three installments beginning 12/04/2016. The combination of option exercises and sizable open-market sales is consistent with liquidity events by insiders. The filing includes footnotes disclosing weighted-average sale prices and offers to provide per-price breakdowns on request, which supports disclosure transparency. No pledging, loans, or unusual derivative structures are reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAUR MICHAEL L

(Last) (First) (Middle)

6 LOGUE COURT

(Street)

GREENVILLE SC 29615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCANSOURCE, INC. [ SCSC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, President, BOD Chair

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		M		102,031	A	$38.19	329,543	D
Common Stock	09/17/2025		S		102,031	D	$44.96(1)	227,512	D
Common Stock	09/18/2025		M		22,969	A	$38.19	250,481	D
Common Stock	09/18/2025		S		47,969	D	$44.34(2)	202,512	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$38.19	09/17/2025		M			102,031	(3)	12/04/2025	Common Stock	102,031	$0	22,969	D
Employee Stock Option (Right to Buy)	$38.19	09/18/2025		M			22,969	(3)	12/04/2025	Common Stock	22,969	$0	0	D

Explanation of Responses:

1. The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $44.25 to $45.23 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $44.15 to $44.66 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The option vested in one-third increments on the anniversary of the grant date on 12/4/2016, 12/4/2017 and 12/4/2018.

	J. Creighton Lynes, attorney-in-fact	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Michael L. Baur report on Form 4 for SCSC?

The report shows option exercises of 102,031 shares on 09/17/2025 and 22,969 shares on 09/18/2025 at a $38.19 exercise price, and open-market sales of 102,031 shares on 09/17/2025 and 47,969 shares on 09/18/2025.

How many shares did Michael L. Baur own after the reported transactions?

Following the transactions, the filing reports beneficial ownership of 202,512 shares as of 09/18/2025.

At what prices were the shares sold according to the filing?

Sales occurred at weighted-average prices of $44.96 (range $44.25–$45.23) and $44.34 (range $44.15–$44.66), with footnotes offering per-price breakdowns on request.

What was the exercise price and vesting history of the options exercised?

The exercised employee stock options had an exercise price of $38.19. The option vested one-third annually on 12/04/2016, 12/04/2017 and 12/04/2018.

Does the Form 4 indicate any derivative holdings remaining after the transactions?

The filing reports 0 derivative securities beneficially owned following the second exercise; the exercised options converted to shares and were reported accordingly.